NCT01164397已完成不适用
Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin to Reduce the Cholesterol Levels in Outpatients in a Realistic Environment. A Retrospective Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 268
- 试验地点
- 1
- 主要终点
- The percentage of the patients that achieve the goal proposed for NCEP ATP III (2001 y 2004) will be assessed, to C-LDL in patients treated with Rosuvastatin or Ezetimibe/Simvastatin at least for 8 weeks.
研究概览
简要总结
The aim of this study is to evaluate the effectiveness of Rosuvastatin versus Ezetimibe/Simvastatin in dyslipidemic patients treated for at least 8 weeks.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Dislipidemic population treated with rosuvastatin or ezetimibe/simvastatin for at least for 8 weeks
- •Who have completed at least 80% of the treatment
- •To have determinations at least of CT, TG C-LDL and CHDL before starting treatment and after 8 weeks of taking the medicine
排除标准
- •Initiating different therapy lipid lowering to Rosuvastatin or Ezetimibe/Simvastatin
结局指标
主要结局
The percentage of the patients that achieve the goal proposed for NCEP ATP III (2001 y 2004) will be assessed, to C-LDL in patients treated with Rosuvastatin or Ezetimibe/Simvastatin at least for 8 weeks.
时间窗: Data will be collected using CRFs after complete at least 15 patients over a 24 week period.
次要结局
- The percentage of LDL-C reduction according to baseline levels in patients treated wuth Rosuvastatin or Ezetimibe/Simvastatin for at least 8 weeks.(Data will be collected using CRFs after complete at least 15 patients over a 24 week period.)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DMAtherosclerotic Cardiovascular DiseaseType 2 Diabetes MellitusNCT03597412Yuhan Corporation236
Unknown
3 期
The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia PatientsHypercholesterolemiaNCT02251847IlDong Pharmaceutical Co Ltd400
已完成
4 期
Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic StrokeStroke, IschemicNCT03993236Keun-Sik Hong584
已完成
不适用
comparison of rosuvastatin alone versus ezetimib plus standard statin on lipid-lowering effects in patients with dyslipidemiadyslipidemiaJPRN-UMIN000002802Department of Medicine II, Hokkaido University Graduate School of Medicine100
已完成
4 期
Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary SyndromeCarotid Atherosclerotic Plaque With InflammationAcute Coronary SyndromeNCT04056169Yuhan Corporation50